Saroja Pharma In — 360° view

Saroja Pharma In, a company in the Specialty Chemicals industry, reported revenue of ₹18 crore and net profit of ₹0.53 crore for the September 2026 quarter.

Saroja Pharma In (NSE: SAROJA-SM) closed at ₹36.00 on 19 Nov 2026, down 14.3% over the past year. Its market capitalisation is ₹14 crore and it trades at 9.2 times earnings.

Share price
₹36.00 (19 Nov 2026)
Market cap
₹14 Cr (19 Nov 2026)
P/E
9.22 (19 Nov 2026)
Revenue
₹18 Cr (September 2026 quarter)
Net profit
₹1 Cr (September 2026 quarter)
ROCE
13.4% (FY26)
ROE
10.1% (FY26)
Book value
₹43.0 (FY26)
Dividend yield
0.00% (last 12 months to 19 Nov 2026)
52-week high / low
₹43.30 / ₹28.00 (19 Nov 2026)
1-year return
-14.3% (to 19 Nov 2026)
Sector
Commodities
Industry
Specialty Chemicals
Symbol
NSE: SAROJA-SM

Incorporated in 2023, Saroja Pharma Ltd is mainly in the business of trading Thionyl Chloride chemical and pharmaceutical intermeddles, etc.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.